Maraviroc Add-on Therapy for Steatohepatitis in HIV
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Pharmacodynamics; Proof of concept
- Acronyms MASH
- 04 Oct 2018 Planned End Date changed from 1 Dec 2019 to 1 Mar 2020.
- 04 Oct 2018 Status changed from active, no longer recruiting to recruiting.
- 03 Apr 2018 Status changed from not yet recruiting to recruiting.